# Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke

> **NCT00472381** · PHASE2,PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 180 (actual)

## Conditions studied

- Acute Stroke
- Acute Cerebral Ischemia

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00472381
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2014-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472381, "Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00472381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*